Results 381 to 390 of about 1,543,966 (410)

Resmetirom for nonalcoholic fatty liver disease: a randomized, double-blind, placebo-controlled phase 3 trial

Nature Medicine, 2023
Stephen Harrison
exaly  

Effect of human umbilical cord-derived mesenchymal stem cells on lung damage in severe COVID-19 patients: a randomized, double-blind, placebo-controlled phase 2 trial

Signal Transduction and Targeted Therapy, 2021
Lei Shi, Chao Zhang, Jin-Wen Song
exaly  

ACC inhibitor alone or co-administered with a DGAT2 inhibitor in patients with non-alcoholic fatty liver disease: two parallel, placebo-controlled, randomized phase 2a trials

Nature Medicine, 2021
Roberto A Calle, Neeta B Amin, Santos Carvajal-Gonzalez   +2 more
exaly  

Placebos

Annals of Internal Medicine, 1982
openaire   +2 more sources

Placebo, effet placebo

EMC - Traité de médecine AKOS, 2006
Patrick Lemoine, Bernard Lachaux
openaire   +1 more source

Aramchol in patients with nonalcoholic steatohepatitis: a randomized, double-blind, placebo-controlled phase 2b trial

Nature Medicine, 2021
, Anna L Fracanzani, Tali Gorfine
exaly  

Tau-targeting antisense oligonucleotide MAPTRx in mild Alzheimer’s disease: a phase 1b, randomized, placebo-controlled trial

Nature Medicine, 2023
Catherine Mummery, Simon Ducharme, Juha O Rinne   +2 more
exaly  

PLACEBOS AND PLACEBOS

The Lancet, 1957
openaire   +1 more source

Randomized, Double-Blind, Phase III Trial of Ipilimumab Versus Placebo in Asymptomatic or Minimally Symptomatic Patients With Metastatic Chemotherapy-Naive Castration-Resistant Prostate Cancer.

Journal of Clinical Oncology, 2017
T. Beer, E. Kwon, C. Drake, K. Fizazi, C. Logothetis, G. Gravis, V. Ganju, J. Polikoff, F. Saad, Piotr Humanski, J. Piulats, P. González Mella, S. Ng, D. Jaeger, F. Parnis, F. Franke, J. Puente, Roman Carvajal, L. Sengeløv, M. McHenry, Arvind Varma, A. V. D. van den Eertwegh, W. Gerritsen   +22 more
semanticscholar   +1 more source

A chimeric hemagglutinin-based universal influenza virus vaccine approach induces broad and long-lasting immunity in a randomized, placebo-controlled phase I trial

Nature Medicine, 2020
Raffael Nachbagauer, Jodi Feser, David I Bernstein   +2 more
exaly